For the approximately one-third of transcatheter aortic valve replacement (TAVR) candidates whose iliofemoral disease makes conventional access difficult, CoreValve implantation via a subclavian ...
Patients with aortic stenosis who undergo transcatheter aortic valve replacement via the subclavian and femoral arteries have equivalent clinical outcomes at 30 days and 1 year, according to a new ...
October 12, 2011 (Lisbon, Portugal)— A recent presentation detailing outcomes from transcatheter aortic-valve implantation (TAVI) performed via the subclavian access route has exposed a battle going ...
Pisa, Italy - Two-year data from the Italian CoreValve (Medtronic) registry provide reassurance that the subclavian route is an acceptable alternative to the transfemoral route for transcatheter ...
Cardiac resynchronization therapy (CRT) is an established and guideline recommended therapy in patients with congestive heart failure with severely reduced systolic function and left bundle branch ...
HOUSTON -- Subclavian access for transcatheter aortic valve replacement (TAVR) cases in which the femoral artery isn't suitable was at least as safe as conventional transfemoral procedures, analysis ...